glaucoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. patients who are at least 18 years of age and less than 80 years of age (regardless of gender) at the time consent is obtained 2. patients whose consent to participate in this study is obtained in writing 3. patients who are deemed by the physician to have ocular fundus diseases that are desirable to be examined 4. patients who are capable of mydriasis
Exclusion criteria
Exclusion criteria: 1. Patients with a history of hypersensitivity to the pupil drug (tropicamide phenylephrine hydrochloride ophthalmic solution) 2. patients who have been judged by the principal investigator or a subinvestigator of the study to be unjustly disadvantaged by participation in the study 3. Patients whose participation in the study has been judged by the principal investigator or a subinvestigator to cause difficulty in the conduct or evaluation of this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| N/A (for data collection study) | — |
Countries
Japan
Contacts
Hiroshima University Hospital Ophthalmology